Related Experiment Video
Updated: May 1, 2026

Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
Advances in targeted delivery of small interfering RNA using simple bioconjugates
Christoffer Nielsen1, Jørgen Kjems, Kristine Rothaus Sørensen
1University of Copenhagen, Copenhagen University Hospital and Biotech Research and Innovation Centre (BRIC), Copenhagen Biocenter, Finsen Laboratory , Ole Maaloes Vej 5, DK-2200 Copenhagen N , Denmark +45 35 45 60 33 ; christoffer.nielsen@finsenlab.dk.
Targeted delivery of small interfering RNA (siRNA) is crucial for RNA interference therapies. This review explores simple bioconjugate constructs designed for cell-specific siRNA delivery, identifying key strategies for therapeutic development.
Area of Science:
- Bioconjugation Chemistry
- RNA Therapeutics
- Drug Delivery Systems
Background:
- RNA interference (RNAi) drug development faces challenges in in vivo delivery.
- Achieving cell-specific delivery of small interfering RNA (siRNA) remains a central problem.
- Bioconjugate constructs offer a strategy for targeted siRNA delivery.
Purpose of the Study:
- To review strategies for cell-specific siRNA delivery using simple bioconjugate constructs.
- To analyze different targeting moieties and conjugation methods.
- To identify key elements for successful siRNA delivery via bioconjugates.
Main Methods:
- Literature review of existing strategies for siRNA bioconjugation.
- Analysis of various targeting moieties and their conjugation approaches.
- Evaluation of inherent functionalities of different bioconjugate strategies.
Main Results:
- Discussion of diverse targeting moieties and conjugation techniques for siRNA bioconjugates.
- Focus on passive and active functionalities enabling cell-specific targeting.
- Identification of critical factors for effective siRNA delivery.
Conclusions:
- Current literature provides insights into effective siRNA bioconjugate strategies.
- Specific concepts and approaches are suitable for future research.
- Development of efficient simple bioconjugates for targeted siRNA delivery holds therapeutic promise.
Related Concept Videos
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Small interfering RNAs (siRNA)

